Simplified Immunosuppression for Kidney Transplant (SIMPLE Trial)

"This trial seeks 80 renal transplant patients in the age range of 18 to 85. Specifically, those with a cold ischemia time (CIT) less than 24 hours for 3-6 HLA mismatches between donor and recipient as well as CIT exceeding 24 hours when there are fewer than three mismatches must meet their selection criteria."

"Affirmative. According to the clinicaltrials.gov page, this study is still in search of patients. It was first posted on November 23rd 2021 and recently updated on June 6th 2022. The research team intends to enroll 80 participants at one medical centre for the duration of the trial."

"Affirmative. The information shared on clinicaltrials.gov implies that this medical trial is still open for recruitment, having been first posted on November 23rd 2021 and last updated June 6th 2022. 80 participants are required across one site in order to further the study's research goals."

"This medical trial has established that applicants must fall within the age range of 18 to 85. For minors, there are 177 trials available and 615 for those over 65 years old."

"Currently, 639 Once-daily Regimen clinical trials are in progress. Of these, 147 have reached Phase 3 of the study. While Philadelphia has a high concentration of trials for this treatment option, there are 18,727 locations participating globally."

"Patients suffering from scalp structure issues, thyroiditis, atopic dermatitis can seek relief through a Once-daily Regimen."

"The once-daily regimen has been approved and is thus rated at 3 on our safety scale. This reflects the fact that this medication is currently in a Phase 4 clinical trial."